Diagnostic utility of PET/CT with 18F-DOPA and 18F-FDG in persistent or recurrent medullary thyroid carcinoma: the importance of calcitonin and carcinoembryonic antigen cutoff

被引:40
作者
Reyes Romero-Lluch, Ana [1 ]
Ignacio Cuenca-Cuenca, Juan [2 ]
Guerrero-Vazquez, Raquel [1 ]
Jesus Martinez-Ortega, Antonio [1 ]
Luis Tirado-Hospital, Juan [2 ]
Borrego-Dorado, Isabel [2 ]
Navarro-Gonzalez, Elena [1 ]
机构
[1] Hosp Univ Virgen del Rocio, Unidad Gest Clin Endocrinol & Nutr, Seville, Spain
[2] Hosp Univ Virgen del Rocio, Unidad Med Nucl, Seville, Spain
关键词
Medullary thyroid carcinoma; F-18-DOPA; F-18-MG; PET/CT; recurrence; POSITRON-EMISSION-TOMOGRAPHY; ASSOCIATION GUIDELINES; FOLLOW-UP; CANCER; MANAGEMENT; RELEVANCE; CT;
D O I
10.1007/s00259-017-3759-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose This study sought to evaluate and compare the utility of 18-F-fluorodihydroxyphenylalanine (F-18-DOPA) and F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT) for identification of lesions in patients with recurrent medullary thyroid carcinoma (MTC). In addition, we analyzed the correlation between the calcitonin (Ct), carcinoembryonic antigen (CEA) levels, each doubling time (DT), and PET positivity. We evaluated the reliability of the 150 pg/mL Ct cutoff set by the American Thyroid Association guidelines for further imaging (including F-18-DOPA PET/CT). Methods We prospectively recruited 18 patients with recurrent MTC, identified by elevation of Ct or CEA. Each patient underwent a F-18-FDG PET/CT and a F-18-DOPA PET/CT. Results Abnormal uptakes were detected with F-18-DOPA (n=12) and F-18-FDG (n=9), (sensitivity of 66.7% vs. 50%; p<0.01). Twenty-eight lesions were detected with F-18-DOPA vs. 16 lesions with F-18-FDG (1.56 +/- 1.5 vs. 0.89 +/- 1.18 lesions per patient; p=0.01). None of our patients showed additional lesions with F-18-FDG in comparison to F-18-DOPA. Patient based detection rate increased significantly with Ct levels >= 150 pg/mL vs. Ct<150 pg/mL for both F-18-DOPA (sensitivity 90.9% vs. 28.6%; p=0.013) and F-18-FDG PET/CT (sensitivity 72.7% vs. 14.3%; p=0.025). Using a CEA cutoff of >= 5 ng/mL, detection rates of F-18-DOPA and F-18-FDG PET/CT were 81.1% and 72.7%, respectively. No correlation between Ct-DT or CEA-DT and PET positivity was found. Histological confirmation was obtained in eight patients. Conclusions F-18-DOPA PET/CT appears to be superior to F-18-FDG PET/CT in detecting and locating lesions in patients with recurrent MTC. This technique tends to be especially useful in patients with negative results in other imaging modalities and Ct >= 150 pg/mL or CEA >= 5 ng/mL.
引用
收藏
页码:2004 / 2013
页数:10
相关论文
共 29 条
[1]   18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma [J].
Archier, Aurelien ;
Heimburger, Celine ;
Guerin, Carole ;
Morange, Isabelle ;
Palazzo, Fausto F. ;
Henry, Jean-Francois ;
Schneegans, Olivier ;
Mundler, Olivier ;
Abdullah, Ahmad Esmaeel ;
Sebag, Frederic ;
Imperiale, Alessio ;
Taieb, David .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (06) :1027-1033
[2]   F-18-Fluorine-18-L-dihydroxyphenylalanine (F-18-DOPA) positive isolated peritoneal carcinomatosis from a MENII-related medullary thyroid carcinoma. About an atypical metastatic site and utility of F-18-FDOPA [J].
Aziz, Anne-Laure ;
Dierickx, Lawrence ;
Courbon, Frederic ;
Taieb, David ;
Zerdoud, Slimane .
CLINICAL CASE REPORTS, 2015, 3 (02) :81-83
[3]   18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type [J].
Balogova, Sona ;
Talbot, Jean-Noel ;
Nataf, Valerie ;
Michaud, Laure ;
Huchet, Virginie ;
Kerrou, Khaldoun ;
Montravers, Francoise .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) :943-966
[4]   The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT [J].
Beheshti, Mohsen ;
Poecher, Sigrid ;
Vali, Reza ;
Waldenberger, Peter ;
Broinger, Gabriele ;
Nader, Michael ;
Kohlfuerst, Susanne ;
Pirich, Christian ;
Dralle, Henning ;
Langsteger, Werner .
EUROPEAN RADIOLOGY, 2009, 19 (06) :1425-1434
[5]   Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma [J].
Beuthien-Baumann, B. ;
Strumpf, A. ;
Zessin, J. ;
Bredow, J. ;
Kotzerke, J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) :1604-1609
[6]   FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0 [J].
Boellaard, Ronald ;
O'Doherty, Mike J. ;
Weber, Wolfgang A. ;
Mottaghy, Felix M. ;
Lonsdale, Markus N. ;
Stroobants, Sigrid G. ;
Oyen, Wim J. G. ;
Kotzerke, Joerg ;
Hoekstra, Otto S. ;
Pruim, Jan ;
Marsden, Paul K. ;
Tatsch, Klaus ;
Hoekstra, Corneline J. ;
Visser, Eric P. ;
Arends, Bertjan ;
Verzijlbergen, Fred J. ;
Zijlstra, Josee M. ;
Comans, Emile F. I. ;
Lammertsma, Adriaan A. ;
Paans, Anne M. ;
Willemsen, Antoon T. ;
Beyer, Thomas ;
Bockisch, Andreas ;
Schaefer-Prokop, Cornelia ;
Delbeke, Dominique ;
Baum, Richard P. ;
Chiti, Arturo ;
Krause, Bernd J. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :181-200
[7]   Comparison of 68Ga-DOTATATE and 18F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma [J].
Conry, Brendon G. ;
Papathanasiou, Nikolaos D. ;
Prakash, Vineet ;
Kayani, Irfan ;
Caplin, Martyn ;
Mahmood, Shahid ;
Bomanji, Jamshed B. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (01) :49-57
[8]   18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels [J].
Hoegerle, S ;
Altehoefer, C ;
Ghanem, N ;
Brink, I ;
Moser, E ;
Nitzsche, E .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (01) :64-71
[9]   Update on Medullary Thyroid Cancer [J].
Hu, Mimi I. ;
Ying, Anita K. ;
Jimenez, Camilo .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2014, 43 (02) :423-+
[10]   Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer [J].
Kauhanen, Saila ;
Schalin-Jantti, Camilla ;
Seppanen, Marko ;
Kajander, Sami ;
Virtanen, Sami ;
Schildt, Jukka ;
Lisinen, Irina ;
Ahonen, Aapo ;
Heiskanen, Ilkka ;
Vaisanen, Mika ;
Arola, Johanna ;
Korsoff, Pirkko ;
Ebeling, Tapani ;
Sane, Timo ;
Minn, Heikki ;
Valimaki, Matti J. ;
Nuutila, Pirjo .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (12) :1855-1863